Published in Biochemistry on August 09, 2008
Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci U S A (2011) 1.50
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease. Alzheimers Res Ther (2013) 0.99
The adipophilin C terminus is a self-folding membrane-binding domain that is important for milk lipid secretion. J Biol Chem (2011) 0.94
Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry (2010) 0.93
APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease. Neurobiol Aging (2012) 0.88
An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines. Neuroscience (2012) 0.85
An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42. J Neurochem (2010) 0.84
Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia. PLoS One (2011) 0.83
Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy. J Lipid Res (2012) 0.83
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT. J Lipid Res (2012) 0.82
ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations. PLoS Comput Biol (2015) 0.81
Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments. J Biomed Sci (2011) 0.80
HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution. Biochemistry (2011) 0.80
Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4. J Biol Chem (2014) 0.79
Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4. Biochim Biophys Acta (2014) 0.78
A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy. Clin Exp Nephrol (2013) 0.76
The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific. Sci Rep (2016) 0.75
Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles. Atherosclerosis (2012) 0.75
Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles. J Biol Chem (2015) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry (1969) 10.58
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res (1992) 3.74
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science (1991) 3.42
Apolipoprotein E structure: insights into function. Trends Biochem Sci (2006) 2.86
Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med (2004) 2.56
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.24
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci U S A (2005) 2.08
Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci (2004) 2.07
Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem (1996) 2.06
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem (1994) 2.04
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry (2000) 2.01
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A (2001) 2.00
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun (2001) 1.91
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem (1988) 1.72
Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J Biol Chem (1988) 1.57
Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J Biol Chem (2002) 1.54
Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet (1981) 1.54
Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. Biophys J (1992) 1.43
Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem (1997) 1.35
Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem (2005) 1.30
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. J Lipid Res (2002) 1.27
The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry (2007) 1.24
A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry (2007) 1.21
Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem (1989) 1.18
Effects of polymorphism on the lipid interaction of human apolipoprotein E. J Biol Chem (2003) 1.17
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J Lipid Res (2007) 1.14
Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. Biochemistry (2006) 1.13
Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. Biochemistry (2003) 1.08
Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. Biochemistry (2008) 1.06
Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3. Eur J Biochem (2001) 1.06
Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion. J Biol Chem (2001) 1.01
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer. Curr Opin Lipidol (2004) 1.01
Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. Biophys J (2004) 0.98
Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Biochim Biophys Acta (2002) 0.98
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry (2005) 0.97
Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein. Structure (1994) 0.96
Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding. J Biol Chem (2002) 0.92
Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. J Biol Chem (1989) 0.89
The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice. Biochemistry (2001) 0.86
A 13 kDa carboxy-terminal fragment of ApoE stabilizes Abeta hexamers. J Neurochem (2005) 0.83
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. Nutr Metab Cardiovasc Dis (2007) 0.83
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res (2010) 1.56
Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol (2011) 1.46
Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol (2011) 1.42
Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. J Biol Chem (2007) 1.32
A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. J Immunol (2012) 1.27
Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ Res (2006) 1.25
The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS One (2008) 1.23
Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry (2004) 1.17
Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res (2004) 1.15
The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing. Biochemistry (2011) 1.12
Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses. Proc Natl Acad Sci U S A (2013) 1.11
Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. Biochem J (2011) 1.10
Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids. Biochemistry (2007) 1.09
Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem J (2007) 1.06
Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1. J Immunol (2010) 1.05
A new role for Zn(II) aminopeptidases: antigenic peptide generation and destruction. Curr Pharm Des (2009) 1.05
Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice. Biochemistry (2005) 1.04
Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation. Biochemistry (2006) 1.02
Male infertility-linked point mutation disrupts the Ca2+ oscillation-inducing and PIP(2) hydrolysis activity of sperm PLCζ. Biochem J (2011) 1.01
Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem (2011) 1.00
Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency. Biochemistry (2005) 0.99
Phospholipase Cζ binding to PtdIns(4,5)P2 requires the XY-linker region. J Cell Sci (2011) 0.98
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry (2005) 0.97
LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice. J Lipid Res (2005) 0.96
Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility. Fertil Steril (2012) 0.95
Inflammatory signaling pathways regulating ApoE gene expression in macrophages. J Biol Chem (2007) 0.95
PLCζ causes Ca(2+) oscillations in mouse eggs by targeting intracellular and not plasma membrane PI(4,5)P(2). Mol Biol Cell (2011) 0.94
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Res Treat (2007) 0.94
Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors. J Biol Chem (2010) 0.93
Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry (2007) 0.93
Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway. Biochem J (2006) 0.93
Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. Mol Biol Cell (2003) 0.92
Lipid-free structure and stability of apolipoprotein A-I: probing the central region by mutation. Biochemistry (2002) 0.92
A dominant negative form of the transcription factor c-Jun affects genes that have opposing effects on lipid homeostasis in mice. J Biol Chem (2007) 0.91
LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN. Biochemistry (2007) 0.90
A continuous fluorigenic assay for the measurement of the activity of endoplasmic reticulum aminopeptidase 1: competition kinetics as a tool for enzyme specificity investigation. Anal Biochem (2009) 0.90
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype. Biochemistry (2003) 0.90
Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT. Biochem J (2007) 0.90
Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity (2013) 0.90
Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells. J Biol Chem (2011) 0.89
The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. Biochemistry (2007) 0.89
Novel regulation of PLCζ activity via its XY-linker. Biochem J (2011) 0.88
Structural and thermodynamic characterization of metal ion binding in Streptococcus suis Dpr. J Mol Biol (2010) 0.86
Enhanced drug transport from unilamellar to multilamellar liposomes induced by molecular recognition of their lipid membranes. Langmuir (2005) 0.86
Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets. Proteins (2009) 0.86
Novel selective inhibitors of aminopeptidases that generate antigenic peptides. Bioorg Med Chem Lett (2013) 0.86
Thermal unfolding of human BRCA1 BRCT-domain variants. Biochim Biophys Acta (2007) 0.86
Influence of confinement in controlled-pore glass on the layer spacing of smectic- a liquid crystals. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 0.85
Calorimetric study of phase transitions in a liquid-crystal-based microemulsion. J Chem Phys (2005) 0.85
Soft-stiff regime crossover for an aerosil network dispersed in liquid crystals. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.85
Nanoparticle-induced widening of the temperature range of liquid-crystalline blue phases. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.84
An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42. J Neurochem (2010) 0.84
Biophysical properties of apolipoprotein E4 variants: implications in molecular mechanisms of correction of hypertriglyceridemia. Biochemistry (2008) 0.84
Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia. PLoS One (2011) 0.83
ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression. J Lipid Res (2005) 0.83
Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy. J Lipid Res (2012) 0.83
Chimeras of sperm PLCζ reveal disparate protein domain functions in the generation of intracellular Ca2+ oscillations in mammalian eggs at fertilization. Mol Hum Reprod (2013) 0.82
A Novel ERAP2 Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk. Mol Genet Genomic Med (2013) 0.82
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT. J Lipid Res (2012) 0.82
The stability of the archaeal HU histone-like DNA-binding protein from Thermoplasma volcanium. Extremophiles (2008) 0.81
The modulation of thermal properties of vinblastine by cholesterol in membrane bilayers. Biochim Biophys Acta (2004) 0.81
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL. J Lipid Res (2011) 0.81
Effect of pH on the structure and stability of Bacillus circulans ssp. alkalophilus phosphoserine aminotransferase: thermodynamic and crystallographic studies. Proteins (2006) 0.81
3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties. J Med Chem (2015) 0.80
Insights into the role of the (alpha+beta) insertion in the TIM-barrel catalytic domain, regarding the stability and the enzymatic activity of chitinase A from Serratia marcescens. Biochim Biophys Acta (2008) 0.80
Interaction of functional dendrimers with multilamellar liposomes: design of a model system for studying drug delivery. Langmuir (2005) 0.79
Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4. J Biol Chem (2014) 0.79
Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide. Biochim Biophys Acta (2010) 0.79
Residues Leu261, Trp264, and Phe265 account for apolipoprotein E-induced dyslipidemia and affect the formation of apolipoprotein E-containing high-density lipoprotein. Biochemistry (2007) 0.79
Role of the hydrophobic and charged residues in the 218-226 region of apoA-I in the biogenesis of HDL. J Lipid Res (2013) 0.79
A simple approach for human recombinant apolipoprotein E4 expression and purification. Protein Expr Purif (2011) 0.79
Domains of apoE4 required for the biogenesis of apoE-containing HDL. Ann Med (2011) 0.78
ATP interacts with the CPVT mutation-associated central domain of the cardiac ryanodine receptor. Biochim Biophys Acta (2013) 0.78
Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational. Handb Exp Pharmacol (2015) 0.78
Fully integrated monolithic optoelectronic transducer for real-time protein and DNA detection: the NEMOSLAB approach. Biosens Bioelectron (2010) 0.78
Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4. J Lipid Res (2010) 0.77
Modeling cell membrane transport: interaction of guanidinylated poly(propylene imine) dendrimers with a liposomal membrane consisting of phosphate-based lipids. Langmuir (2006) 0.77
Calorimetric study of the interaction of binary DMTAP/DOTAP cationic liposomes with plasmid DNA. J Liposome Res (2009) 0.77
Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux. PLoS One (2013) 0.77
Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL. J Lipid Res (2013) 0.77
Generation and characterization of two transgenic mouse lines expressing human ApoE2 in neurons and glial cells. Biochemistry (2002) 0.77